HK1060855A1 - Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function - Google Patents

Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function

Info

Publication number
HK1060855A1
HK1060855A1 HK04103932A HK04103932A HK1060855A1 HK 1060855 A1 HK1060855 A1 HK 1060855A1 HK 04103932 A HK04103932 A HK 04103932A HK 04103932 A HK04103932 A HK 04103932A HK 1060855 A1 HK1060855 A1 HK 1060855A1
Authority
HK
Hong Kong
Prior art keywords
ofdelayed
medicament
manufacture
treatment
graft function
Prior art date
Application number
HK04103932A
Other languages
English (en)
Inventor
Marc Bigaud
Volker Brinkmann
Tomasz Sablinski
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0104438A external-priority patent/GB0104438D0/en
Priority claimed from GB0105000A external-priority patent/GB0105000D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1060855A1 publication Critical patent/HK1060855A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK04103932A 2001-02-22 2004-06-01 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function HK1060855A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0104438A GB0104438D0 (en) 2001-02-22 2001-02-22 Organic compounds
GB0105000A GB0105000D0 (en) 2001-02-28 2001-02-28 Organic compounds
PCT/EP2002/001860 WO2002067915A1 (fr) 2001-02-22 2002-02-21 Utilisation d'agents de homing lymphocytaire accelere pour la production d'un medicament destine au traitement de la reprise fonctionnelle retardee du greffon

Publications (1)

Publication Number Publication Date
HK1060855A1 true HK1060855A1 (en) 2004-08-27

Family

ID=26245749

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04103932A HK1060855A1 (en) 2001-02-22 2004-06-01 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function

Country Status (12)

Country Link
US (2) US20040087662A1 (fr)
EP (1) EP1368015B1 (fr)
JP (1) JP4318921B2 (fr)
CN (1) CN100479814C (fr)
AT (1) ATE335475T1 (fr)
BR (1) BR0207434A (fr)
CA (1) CA2435739A1 (fr)
DE (1) DE60213766T2 (fr)
ES (1) ES2267993T3 (fr)
HK (1) HK1060855A1 (fr)
PT (1) PT1368015E (fr)
WO (1) WO2002067915A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1429845E (pt) * 2001-06-08 2009-06-15 Novartis Ag Tratamento ou profilaxia da rejeição de enxertos de células produtoras de insulina
KR100836547B1 (ko) 2002-01-11 2008-06-10 상꾜 가부시키가이샤 아미노 알코올 유도체 또는 포스폰산 유도체 및 이들을함유하는 의약 조성물
WO2005079788A1 (fr) 2004-02-24 2005-09-01 Sankyo Company, Limited Composé d’alcool aminé
PL1772145T3 (pl) * 2004-07-16 2011-08-31 Kyorin Seiyaku Kk Sposób skutecznego stosowania leku i sposób dotyczący zapobiegania efektom ubocznym
PT2511262T (pt) * 2004-10-12 2017-03-30 Kyorin Seiyaku Kk Processo para a produção de cloridrato de 2-amino-2-[2-[4-(3- benziloxi-feniltio)-2-clorofenil[etil]-1,3-propanodiol
PT1932522E (pt) * 2005-10-07 2012-06-26 Kyorin Seiyaku Kk Agente terapêutico para doenças do fígado contendo, como princípio activo, um derivado de 2- amino-1,3-propanodiol
TWI389683B (zh) * 2006-02-06 2013-03-21 Kyorin Seiyaku Kk A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
NZ574012A (en) * 2006-08-08 2012-02-24 Kyorin Seiyaku Kk Aminoalcohol derivative and immunosuppressant containing the same as active ingredient
CN101501049B (zh) * 2006-08-08 2013-04-24 杏林制药株式会社 氨基磷酸酯衍生物以及将它们作为有效成分的s1p受体调节剂
JP5452237B2 (ja) 2008-02-07 2014-03-26 杏林製薬株式会社 アミノアルコール誘導体を有効成分とする炎症性腸疾患の治療剤又は予防剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928572A (en) * 1971-02-11 1975-12-23 Ayerst Mckenna & Harrison Myriocin and process of preparation
ATE172711T1 (de) * 1992-10-21 1998-11-15 Yoshitomi Pharmaceutical 2-amino-1, 3- propandiolverbindung und immunosuppressium
CA2213989C (fr) * 1995-12-28 2007-05-29 Yoshitomi Pharmaceutical Industries Ltd. Preparation a usage externe
GB9624038D0 (en) * 1996-11-19 1997-01-08 Sandoz Ltd Organic compounds
DK1002792T3 (da) * 1997-04-04 2004-11-22 Mitsubishi Pharma Corp 2-aminopropan-1,3-diolforbindelser, medicinsk anvendelse deraf og mellemprodukter til syntese af disse
JPH1180026A (ja) * 1997-09-02 1999-03-23 Yoshitomi Pharmaceut Ind Ltd 新規免疫抑制剤、その使用方法およびその同定方法
PT1429845E (pt) * 2001-06-08 2009-06-15 Novartis Ag Tratamento ou profilaxia da rejeição de enxertos de células produtoras de insulina

Also Published As

Publication number Publication date
PT1368015E (pt) 2006-12-29
ES2267993T3 (es) 2007-03-16
US20040087662A1 (en) 2004-05-06
DE60213766D1 (de) 2006-09-21
CN100479814C (zh) 2009-04-22
CN1492757A (zh) 2004-04-28
WO2002067915A1 (fr) 2002-09-06
BR0207434A (pt) 2004-07-06
ATE335475T1 (de) 2006-09-15
CA2435739A1 (fr) 2002-09-06
EP1368015B1 (fr) 2006-08-09
JP4318921B2 (ja) 2009-08-26
JP2004527490A (ja) 2004-09-09
US20080015261A1 (en) 2008-01-17
DE60213766T2 (de) 2007-08-02
EP1368015A1 (fr) 2003-12-10

Similar Documents

Publication Publication Date Title
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
WO2004039248A3 (fr) Reparation ou remplacement de tissus ou d'organes
AU2001273276A1 (en) Improving effectiveness of medical stents by gcib
TW200714283A (en) Method and composition for treating peripheral vascular diseases
ATE539701T1 (de) Zusammengesetzte schlinge zur behandlung von inkontinenz
UA88418C2 (ru) Синергическая фунгицидная комбинация активных веществ и их применение для борьбы с нежелательными фитопатогенными грибами
WO2003000200A3 (fr) ss-2'-OU 3'-HALONUCLEOSIDES
DE60235928D1 (de) Mittel zur Suppression von Transplantat-Abstossung
PL1646634T3 (pl) Zastosowanie rapamycyny i pochodnych rapamycyny w leczeniu utraty kości
HK1047404B (zh) 血管膜合成物
MXPA06000123A (es) Suspension aislante de apoyo central de resorte rapido de plastico y metodo para fabricar y ensamblar el mismo.
WO2004031129A3 (fr) Nouveaux composes destines au traitement des maladies auto-immunes, des maladies immuno-allergiques et des rejets en cas de greffes d'organes ou de tissus
WO2006034001A3 (fr) Procedes de traitement de l'infection par vih
WO2003103662A3 (fr) Inhibiteurs de la glycoproteine vi
HK1060855A1 (en) Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function
DK1178726T3 (da) Vandig opløsning til konservering af væv og organer
EP1162956B8 (fr) Compositions et methodes pour l'amelioration de l'integrite de cavites et de passages corporels affaiblis
MXPA04003755A (es) Endoprotesis vasculares.
DK1569679T3 (da) Chaperonin-10-immunosuppression
WO2004091436A3 (fr) Procedes et compositions permettant de traiter des maladies oculaires
GB2454154A (en) Aglet for attachment to a graft material
WO2007016580A3 (fr) Silençage de molecules d'arn et utilisation dans la formation des os
MXPA05012742A (es) Composiciones de tratamiento para el cabello.
TW200514553A (en) Therapeutic agent for hepatitis C
IL169784A0 (en) Spermicidal and fungicidal compositions containing hexahydroindenopyridine derivatives and methods utilizing the same

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100221